Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Head and Neck Cancer

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 89 articles: HTML format Text format

Single Articles

February 2010
1. HUI AB , Lenarduzzi M, Krushel T, Waldron L, et al
   Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas.
   Clin Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
2. MEYER F , Samson E, Douville P, Duchesne T, et al
   Serum Prognostic Markers in Head and Neck Cancer.
   Clin Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. SUN W , Liu Y, Glazer CA, Shao C, et al
   TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1{alpha} Stabilization.
   Clin Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. KATO H , Ito E, Shi W, Alajez NM, et al
   Efficacy of Combining GMX1777 with Radiation Therapy for Human Head and Neck Carcinoma.
   Clin Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. WANG WY , Twu CW, Chen HH, Jan JS, et al
   Plasma EBV DNA Clearance Rate as a Novel Prognostic Marker for Metastatic/Recurrent Nasopharyngeal Carcinoma.
   Clin Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. WANG LE , Hu Z, Sturgis EM, Spitz MR, et al
   Reduced DNA Repair Capacity for Removing Tobacco Carcinogen-Induced DNA Adducts Contributes to Risk of Head and Neck Cancer but not Tumor Characteristics.
   Clin Cancer Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
7. GOTO M , Mitra RS, Liu M, Lee J, et al
   Rap1 Stabilizes {beta}-Catenin and Enhances {beta}-Catenin-Dependent Transcription and Invasion in Squamous Cell Carcinoma of the Head and Neck.
   Clin Cancer Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. KLINGHAMMER K , Knodler M, Schmittel A, Budach V, et al
   Association of Epidermal Growth Factor Receptor Polymorphism, Skin Toxicity, and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment.
   Clin Cancer Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. LIN J , Guan Z, Wang C, Feng L, et al
   Inhibitor of Differentiation 1 Contributes to Head and Neck Squamous Cell Carcinoma Survival via the NF-{kappa}B/Survivin and Phosphoinositide 3-Kinase/Akt Signaling Pathways.
   Clin Cancer Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. POETA ML , Manola J, Goldenberg D, Forastiere A, et al
    The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. SCHAAIJ-VISSER TB , Graveland AP, Gauci S, Braakhuis BJ, et al
    Differential Proteomics Identifies Protein Biomarkers That Predict Local Relapse of Head and Neck Squamous Cell Carcinomas.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. NEMUNAITIS J , Clayman G, Agarwala SS, Hrushesky W, et al
    Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
13. LI Y , Li LJ, Zhang ST, Wang LJ, et al
    In vitro and clinical studies of gene therapy with recombinant human adenovirus-p53 injection for oral leukoplakia.
    Clin Cancer Res. 2009;15:6724-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
14. CHUNG CH , Gillison ML
    Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. MANDAPATHIL M , Szczepanski MJ, Szajnik M, Ren J, et al
    Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.
    Clin Cancer Res. 2009;15:6348-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. EGLOFF AM , Rothstein ME, Seethala R, Siegfried JM, et al
    Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ST JOHN MA , Dohadwala M, Luo J, Wang G, et al
    Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.
    Clin Cancer Res. 2009;15:6018-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. ARUN P , Brown MS, Ehsanian R, Chen Z, et al
    Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.
    Clin Cancer Res. 2009;15:5974-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
19. SAINTIGNY P , El-Naggar AK, Papadimitrakopoulou V, Ren H, et al
    {Delta}Np63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. PARK NJ , Zhou H, Elashoff D, Henson BS, et al
    Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
21. BRADBURY PA , Zhai R, Ma C, Xu W, et al
    Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. WEI F , Patel P, Liao W, Chaudhry K, et al
    Electrochemical sensor for multiplex biomarkers detection.
    Clin Cancer Res. 2009;15:4446-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
23. ZHANG C , Fu L, Fu J, Hu L, et al
    Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma.
    Clin Cancer Res. 2009;15:4017-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. HUANG KH , Huang SF, Chen IH, Liao CT, et al
    Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
    Clin Cancer Res. 2009;15:4174-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LI J , Huang H, Sun L, Yang M, et al
    MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
    Clin Cancer Res. 2009;15:3998-4008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. DEAN NR , Newman JR, Helman EE, Zhang W, et al
    Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
27. HUI AB , Yue S, Shi W, Alajez NM, et al
    Therapeutic Efficacy of Seliciclib in Combination with Ionizing Radiation for Human Nasopharyngeal Carcinoma.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. NUCERA C , Eeckhoute J, Finn S, Carroll JS, et al
    FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. KNOWLES LM , Stabile LP, Egloff AM, Rothstein ME, et al
    HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. PAULSON TG , Maley CC, Li X, Li H, et al
    Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Clin Cancer Res. 2009;15:3305-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
31. CESCON DW , Bradbury PA, Asomaning K, Hopkins J, et al
    p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. AVISSAR M , Christensen BC, Kelsey KT, Marsit CJ, et al
    MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. SAVANI BN , Goodman S, Barrett AJ
    Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation?
    Clin Cancer Res. 2009;15:2219-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
34. PERNAS FG , Allen CT, Winters ME, Yan B, et al
    Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. KURIHARA Y , Watanabe Y, Onimatsu H, Kojima T, et al
    Telomerase-Specific Virotheranostics for Human Head and Neck Cancer.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. HIYOSHI Y , Kamohara H, Karashima R, Sato N, et al
    MicroRNA-21 Regulates the Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. KANAZAWA T , Kommareddi PK, Iwashita T, Kumar B, et al
    Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells.
    Clin Cancer Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. GILL KR , Wolfsen HC, Preyer NW, Scott MV, et al
    Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Clin Cancer Res. 2009;15:1830-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MICHAUD WA , Nichols AC, Mroz EA, Faquin WC, et al
    Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.
    Clin Cancer Res. 2009;15:1645-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. WU F , Zhu S, Ding Y, Beck WT, et al
    MicroRNA-mediated regulation of Ubc9 expression in cancer cells.
    Clin Cancer Res. 2009;15:1550-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. KLUSSMANN JP , Mooren JJ, Lehnen M, Claessen SM, et al
    Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Clin Cancer Res. 2009;15:1779-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. BENAVENTE S , Huang S, Armstrong EA, Chi A, et al
    Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.
    Clin Cancer Res. 2009;15:1585-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
43. MENDEZ E , Houck JR, Doody DR, Fan W, et al
    A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival.
    Clin Cancer Res. 2009;15:1353-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. HSIEH WS , Soo R, Peh BK, Loh T, et al
    Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer.
    Clin Cancer Res. 2009;15:1435-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. GEURTS TW , van Velthuysen ML, Broekman F, Hooft van Huysduynen T, et al
    Differential Diagnosis of Pulmonary Carcinoma Following Head and Neck Cancer by Genetic Analysis.
    Clin Cancer Res. 2009;15:980-985.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. KIM S , Loevner L, Quon H, Sherman E, et al
    Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.
    Clin Cancer Res. 2009;15:986-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
47. HADDAD Y , Choi W, McConkey DJ
    Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.
    Clin Cancer Res. 2009;15:532-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. HENDERSON YC , Shellenberger TD, Williams MD, El-Naggar AK, et al
    High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid Carcinoma.
    Clin Cancer Res. 2009;15:485-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. SUN W , Zhou S, Chang SS, McFate T, et al
    Mitochondrial Mutations Contribute to HIF1{alpha} Accumulation via Increased Reactive Oxygen Species and Up-regulated Pyruvate Dehydrogenease Kinase 2 in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2009;15:476-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HIRATA D , Yamabuki T, Miki D, Ito T, et al
    Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
    Clin Cancer Res. 2009;15:256-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. GUILHEN AC , Bufalo NE, Morari EC, Leite JL, et al
    Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility.
    Clin Cancer Res. 2009;15:406-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
52. LANGER R , Ott K, Specht K, Becker K, et al
    Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response.
    Clin Cancer Res. 2008;14:8279-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. CUI L , Xu LY, Shen ZY, Tao Q, et al
    NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma.
    Clin Cancer Res. 2008;14:7674-7681.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. MISAWA K , Ueda Y, Kanazawa T, Misawa Y, et al
    Epigenetic inactivation of galanin receptor 1 in head and neck cancer.
    Clin Cancer Res. 2008;14:7604-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. GUPTA VK , Feber A, Xi L, Pennathur A, et al
    Association between CCND1 G/A870 Polymorphism, Allele-Specific Amplification, Cyclin D1 Expression, and Survival in Esophageal and Lung Carcinoma.
    Clin Cancer Res. 2008;14:7804-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. KOPPIKAR P , Lui VW, Man D, Xi S, et al
    Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting.
    Clin Cancer Res. 2008;14:7682-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
57. MAO YP , Liang SB, Liu LZ, Chen Y, et al
    The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging.
    Clin Cancer Res. 2008;14:7497-503.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. GELBARD A , Kupferman ME, Jasser SA, Chen W, et al
    An orthotopic murine model of sinonasal malignancy.
    Clin Cancer Res. 2008;14:7348-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. AGRAWAL Y , Koch WM, Xiao W, Westra WH, et al
    Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16-Positive and Human Papillomavirus 16-Negative Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2008;14:7143-7150.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. CHANG KP , Hao SP, Chang JH, Wu CC, et al
    Macrophage Inflammatory Protein-3{alpha} Is a Novel Serum Marker for Nasopharyngeal Carcinoma Detection and Prediction of Treatment Outcomes.
    Clin Cancer Res. 2008;14:6979-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. HUI EP , Sung FL, Yu BK, Wong CS, et al
    Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.
    Clin Cancer Res. 2008;14:7080-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. CHAO DL , Sanchez CA, Galipeau PC, Blount PL, et al
    Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.
    Clin Cancer Res. 2008;14:6988-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. YONESAKA K , Zejnullahu K, Lindeman N, Homes AJ, et al
    Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.
    Clin Cancer Res. 2008;14:6963-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. O-CHAROENRAT P , Sarkaria I, Talbot SG, Reddy P, et al
    SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2.
    Clin Cancer Res. 2008;14:6780-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. SOK JC , Grandis JR
    Genetic screening for oral human papillomavirus infections and cancers of the head and neck.
    Clin Cancer Res. 2008;14:6723-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
66. LIBERTINI S , Iacuzzo I, Perruolo G, Scala S, et al
    Bevacizumab Increases Viral Distribution in Human Anaplastic Thyroid Carcinoma Xenografts and Enhances the Effects of E1A-Defective Adenovirus dl922-947.
    Clin Cancer Res. 2008;14:6505-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. SABO E , Meitner PA, Tavares R, Corless CL, et al
    Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.
    Clin Cancer Res. 2008;14:6440-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. CHEN K , Zhao H, Hu Z, Wang LE, et al
    CASP3 Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck.
    Clin Cancer Res. 2008;14:6343-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. HU S , Arellano M, Boontheung P, Wang J, et al
    Salivary Proteomics for Oral Cancer Biomarker Discovery.
    Clin Cancer Res. 2008;14:6246-6252.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. WANG D , Veena MS, Stevenson K, Tang C, et al
    Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor {kappa}B by an AKT-Independent Pathway.
    Clin Cancer Res. 2008;14:6228-6236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. HATANO H , Kudo Y, Ogawa I, Tsunematsu T, et al
    IFN-Induced Transmembrane Protein 1 Promotes Invasion at Early Stage of Head and Neck Cancer Progression.
    Clin Cancer Res. 2008;14:6097-6105.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
72. SCHUMAKER L , Nikitakis N, Goloubeva O, Tan M, et al
    Elevated expression of glutathione S-transferase pi and p53 confers poor prognosis in head and neck cancer patients treated with chemoradiotherapy but not radiotherapy alone.
    Clin Cancer Res. 2008;14:5877-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. CHIANG FY , Wu CW, Hsiao PJ, Kuo WR, et al
    Association between Polymorphisms in DNA Base Excision Repair Genes XRCC1, APE1, and ADPRT and Differentiated Thyroid Carcinoma.
    Clin Cancer Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. TSUJI A , Wakisaka N, Kondo S, Murono S, et al
    Induction of Receptor for Advanced Glycation End Products by EBV Latent Membrane Protein 1 and Its Correlation with Angiogenesis and Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma.
    Clin Cancer Res. 2008;14:5368-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
75. RAO PH , Roberts D, Zhao YJ, Bell D, et al
    Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands.
    Clin Cancer Res. 2008;14:5181-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. CHOI S , Sano D, Cheung M, Zhao M, et al
    Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model.
    Clin Cancer Res. 2008;14:5081-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. HENDERSON YC , Ahn SH, Kang Y, Clayman GL, et al
    Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.
    Clin Cancer Res. 2008;14:4908-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. ALAJEZ NM , Mocanu JD, Shi W, Chia MC, et al
    Efficacy of systemically administered mutant vesicular stomatitis virus (VSVDelta51) combined with radiation for nasopharyngeal carcinoma.
    Clin Cancer Res. 2008;14:4891-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. CHAN KC , Leung SF, Yeung SW, Chan AT, et al
    Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients.
    Clin Cancer Res. 2008;14:4809-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. OLER G , Camacho CP, Hojaij FC, Michaluart P Jr, et al
    Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.
    Clin Cancer Res. 2008;14:4735-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
81. WATANABE N , Takaoka M, Sakurama K, Tomono Y, et al
    Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
    Clin Cancer Res. 2008;14:4631-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. ZHAI X , Zhao H, Liu Z, Wang LE, et al
    Functional variants of the NEIL1 and NEIL2 genes and risk and progression of squamous cell carcinoma of the oral cavity and oropharynx.
    Clin Cancer Res. 2008;14:4345-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. PAPEWALIS C , Wuttke M, Seissler J, Meyer Y, et al
    Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer.
    Clin Cancer Res. 2008;14:4298-305.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. ALEXANDER AA , Maniar A, Cummings JS, Hebbeler AM, et al
    Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma.
    Clin Cancer Res. 2008;14:4232-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
85. BHATTACHARYA A , Seshadri M, Oven SD, Toth K, et al
    Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs.
    Clin Cancer Res. 2008;14:3926-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. PRASAD NB , Somervell H, Tufano RP, Dackiw AP, et al
    Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors.
    Clin Cancer Res. 2008;14:3327-3337.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
87. LANUTI M , Liu G, Goodwin JM, Zhai R, et al
    A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
    Clin Cancer Res. 2008;14:3216-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. LEE ES , Issa JP, Roberts DB, Williams MD, et al
    Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Clin Cancer Res. 2008;14:2664-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. WONG TS , Liu XB, Wong BY, Ng RW, et al
    Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue.
    Clin Cancer Res. 2008;14:2588-92.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: